H2O AM’s Ionis Pharmaceuticals IONS Stock Holding History

H2O AM’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-74,700	Closed	-$3.84M	–	75
2018 Q4	$3.84M	Buy	+74,700	New	+$3.81M	0.42%	44

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

H2O AM's IONS Position: Q1 2019 in Review

H2O AM sold out of Ionis Pharmaceuticals (IONS) in Q1 2019, closing a stake of 74,700 shares — an estimated $3.84M sold.

H2O AM first reported a position in IONS in Q4 2018 and held it in 1 quarter. The position peaked at $3.84M in Q4 2018. 393 funds tracked by Wall St. Rank hold IONS as of Q1 2019.

H2O AM reported no remaining Ionis Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
H2O AM sold 74,700 Ionis Pharmaceuticals shares in Q1 2019, an estimated $3.84M.
H2O AM first reported a position in Ionis Pharmaceuticals in Q4 2018 and held it in 1 quarter.
H2O AM's Ionis Pharmaceuticals position peaked at $3.84M in Q4 2018.
393 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2019.

Based on H2O AM's 13F filing for Q1 2019, filed 15 May 2019.